Syneos Health Inc - Class A
SYNH
Market Cap$0
Close$
$43.99
2.3% upside
Current Fair Value
2.3% upsideUndervalued by 2.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $0.00 |
|---|---|
| Enterprise Value | $2.62 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $0.69 |
| Beta | 0.0 |
| Outstanding Shares | 103,719,179 |
| Avg 30 Day Volume | 0 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 0.0 |
|---|---|
| PEG | -0.0 |
| Price to Sales | 0.83 |
| Price to Book Ratio | 1.3 |
| Enterprise Value to Revenue | 0.48 |
| Enterprise Value to EBIT | 7.65 |
| Enterprise Value to Net Income | 36 |
| Total Debt to Enterprise | 1.03 |
| Debt to Equity | 0.77 |
Revenue Sources
No data
ESG Score
No data
About Syneos Health Inc
23,000 employees
CEO: Alistair Macdonald Syneos Health is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer perfor...